Inhibitors | Comment | Organism | Structure |
---|---|---|---|
(2Z)-2-[(4-methoxyphenyl)carbonyl]-3-(2,3,4-trimethoxyphenyl)prop-2-enoic acid | - |
Homo sapiens | |
(2Z)-2-[(4-methylphenyl)carbonyl]-3-(2,3,4-trimethoxyphenyl)prop-2-enoic acid | - |
Homo sapiens | |
(2Z)-2-[(4-methylphenyl)carbonyl]-3-phenylprop-2-enoic acid | 8.1% inhibition at 0.02 mM | Homo sapiens | |
(2Z)-3-(1,3-benzodioxol-5-yl)-2-[(4-methoxyphenyl)carbonyl]prop-2-enoic acid | 10% inhibition at 0.02 mM | Homo sapiens | |
(2Z)-3-(1,3-benzodioxol-5-yl)-2-[(4-methylphenyl)carbonyl]prop-2-enoic acid | 9.6% inhibition at 0.02 mM | Homo sapiens | |
(2Z)-3-(2-methylphenyl)-2-[(4-methylphenyl)carbonyl]prop-2-enoic acid | 9.3% inhibition at 0.02 mM | Homo sapiens | |
(2Z)-3-(3,4-dihydroxyphenyl)-2-[(4-methoxyphenyl)carbonyl]prop-2-enoic acid | - |
Homo sapiens | |
(2Z)-3-(3,4-dihydroxyphenyl)-2-[(4-methylphenyl)carbonyl]prop-2-enoic acid | - |
Homo sapiens | |
(2Z)-3-(3-hydroxyphenyl)-2-[(4-methoxyphenyl)carbonyl]prop-2-enoic acid | 6.6% inhibition at 0.02 mM | Homo sapiens | |
(2Z)-3-(3-hydroxyphenyl)-2-[(4-methylphenyl)carbonyl]prop-2-enoic acid | 13.9% inhibition at 0.02 mM | Homo sapiens | |
(2Z)-3-(3-methoxyphenyl)-2-[(4-methylphenyl)carbonyl]prop-2-enoic acid | 19.0% inhibition at 0.02 mM | Homo sapiens | |
(2Z)-3-(4-chlorophenyl)-2-[(4-methoxyphenyl)carbonyl]prop-2-enoic acid | 14.4% inhibition at 0.02 mM | Homo sapiens | |
(2Z)-3-(4-chlorophenyl)-2-[(4-methylphenyl)carbonyl]prop-2-enoic acid | 14.4% inhibition at 0.02 mM | Homo sapiens | |
(2Z)-3-(4-fluorophenyl)-2-[(4-methylphenyl)carbonyl]prop-2-enoic acid | - |
Homo sapiens | |
(2Z)-3-(4-hydroxy-3-methoxyphenyl)-2-[(4-methylphenyl)carbonyl]prop-2-enoic acid | 8.8% inhibition at 0.02 mM | Homo sapiens | |
(2Z)-3-(4-hydroxyphenyl)-2-[(4-methylphenyl)carbonyl]prop-2-enoic acid | 12.5% inhibition at 0.02 mM | Homo sapiens | |
(2Z)-3-(4-methoxyphenyl)-2-[(4-methylphenyl)carbonyl]prop-2-enoic acid | - |
Homo sapiens | |
(2Z)-3-(4-methylphenyl)-2-[(4-methylphenyl)carbonyl]prop-2-enoic acid | - |
Homo sapiens | |
(2Z)-3-[4-(dimethylamino)phenyl]-2-[(4-methylphenyl)carbonyl]prop-2-enoic acid | 9.3% inhibition at 0.02 mM | Homo sapiens | |
Ethacrynic acid | 88.6% inhibition at 0.02 mM | Homo sapiens | |
additional information | inhibitory potencies of chalcone derivatives on GSTP1-1, molecular modeling, overview. No or poor inhibition by I-02, I-03, I-10, I-13, I-14, I-15, and I-16 | Homo sapiens |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | - |
isozyme GSTP1-1 | - |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
HL-60 cell | - |
Homo sapiens | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
glutathione + 1-chloro-2,4-dinitrobenzene | - |
Homo sapiens | S-(2,4-dinitrophenyl)glutathione + HCl | - |
? |
Synonyms | Comment | Organism |
---|---|---|
glutathione S-transferase P1-1 | - |
Homo sapiens |
GSTP1-1 | - |
Homo sapiens |
Temperature Optimum [°C] | Temperature Optimum Maximum [°C] | Comment | Organism |
---|---|---|---|
25 | - |
assay at | Homo sapiens |
pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|
6.8 | - |
assay at | Homo sapiens |
General Information | Comment | Organism |
---|---|---|
metabolism | glutathione S-transferase P1-1 is one of the most important members of phase II detoxification enzyme family which catalyzes the conjugation of glutathione with broad substrates such as chemotherapeutic agents | Homo sapiens |